Dudum Andrew's Form 4 filing
Hims & Hers Health, Inc. (HIMS) · filed Dec 29, 2023
- Accession no.
- 0001773751-23-000323
- Filed
- Dec 29, 2023
- Trade date
- Dec 27-29, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 6 non-derivative transactions and 3 derivative transactions. Open-market sales total $495.6K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Dudum AndrewCIK 0001837796 | Director, Officer (Chief Executive Officer), 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 27, 2023 | Class A Common Stock | MOption exerciseAcquired | +7,700 | $2.43 | +$18,711 | 59,353 | Direct | |
| Dec 27, 2023 | Class A Common Stock | SSaleDisposed | −7,700 | $9.02F2 | −$69,454 | 51,653 | Direct | |
| Dec 28, 2023 | Class A Common Stock | MOption exerciseAcquired | +25,750 | $2.43 | +$62,572.5 | 77,403 | Direct | |
| Dec 28, 2023 | Class A Common Stock | SSaleDisposed | −25,750 | $9.01F3 | −$232,007.5 | 51,653 | Direct | |
| Dec 29, 2023 | Class A Common Stock | MOption exerciseAcquired | +21,432 | $2.43 | +$52,079.76 | 73,085 | Direct | |
| Dec 29, 2023 | Class A Common Stock | SSaleDisposed | −21,432 | $9.06F4 | −$194,173.92 | 51,653 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 27, 2023 | Class A Common Stock | MOption exerciseDisposed | −7,700 | $0.00 | $0 | 2,980,064 | Direct | |
| Dec 28, 2023 | Class A Common Stock | MOption exerciseDisposed | −25,750 | $0.00 | $0 | 2,954,314 | Direct | |
| Dec 29, 2023 | Class A Common Stock | MOption exerciseDisposed | −21,432 | $0.00 | $0 | 2,932,882 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $9.00 - $9.075. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F3
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $9.00 - $9.035. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F4
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $9.01 - $9.12. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.